Blog
Is Amazon a Bad News Buy?
Higher inflation has been weighing on Amazon's (NASDAQ: AMZN) e-commerce business for about a year. But the company's other big business -- cloud computing services -- has defied the pressure
2 Growth Stocks on My Buy List
Growth stocks have been hit the hardest in the ongoing bear market. That's because they typically rise the fastest when markets are charging higher, resulting in lofty valuations. While the steep
What Does Apple's Controversial NFT Policy Mean for Ethereum and Solana?
The good news is that Apple (NASDAQ: AAPL) is now supporting non-fungible tokens (NFTs) in its App Store. Given Apple's massive influence in the tech world, this would seem to signal the future
Don't Get Used to Lower Medicare Part B Premiums -- Here's Why
Many retirees are probably counting down the days until their monthly Social Security check increases. And there's even more financial help on the way. Seniors on Medicare recently received some
Before Theranos, Before Enron, There Was Crazy Eddie.
Founded by Eddie Antar, Crazy Eddie was a chain of consumer electronic stores in the Northeast. After going public in the 1980s, the stock became nearly a 10-bagger before investigators found it to
Is General Motors Stock Poised for a Turnaround? 3 Charts That Might Convince You
Detroit automaker General Motors (NYSE: GM), has shed roughly 35% of its value year to date as the company faced chip shortages, economic uncertainty, and the potential for rising interest rates to
Should You Sell Your Spotify Stock Now?
Did you hear the news? Recently, the world's leading audio-streaming business disappointed investors with a less-than-glowing quarterly earnings report. Despite already falling by more than half
QuantumScape: The 1 Thing You Need to Learn From Its Quarterly Report
Next-gen battery start-up QuantumScape (NYSE: QS) filed its third-quarter report on Oct. 26, giving investors an update on progress bringing its solid-state tech to market. But since it's
Alphabet Stock Is Down After Earnings: Time to Buy or Time to Bail?
Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) reported third-quarter results on October 25, and shares have fallen by double digits since. Revenue was up a modest 6%, half the growth rate of the first half
Nasdaq Bear Market: 5 Magnificent Growth Stocks You'll Regret Not Buying on the Dip
For most investors, 2022 hasn't gone as planned. Following a year where the biggest drawdown in the S&P 500 totaled just 5%, the benchmark index has responded in 2022 by plunging into a bear market
Social Security Benefits Are Rising in 2023 -- but You'll Shrink Yours If You Do This
Millions of seniors regard Social Security as a major retirement income source. And for some, those monthly benefits are their only source of income.
Meanwhile, seniors on Social Security recently
4 Social Security Changes Joe Biden Wants to Enact: Will Midterm Elections Help His Cause?
In September, 65.8 million people received a Social Security benefit, including more than 48 million retired workers. The vast majority of these retirees -- 89%, to be exact -- need their Social
VICI Properties Inc. (VICI) Q3 2022 Earnings Call Transcript
Image source: The Motley Fool.
VICI Properties Inc. (NYSE: VICI)Q3 2022 Earnings CallOct 28, 2022, 9:00 a.m. ET
Operator
Source Fool.com
Why Shares of Universal Health Services Spiked 30% This Week
Shares of Universal Health Services (NYSE: UHS) climbed 30% this week, according to data from S&P Global Intelligence. The hospital and health-facility services provider saw its shares close last
Camden Property Trust (CPT) Q3 2022 Earnings Call Transcript
Image source: The Motley Fool.
Camden Property Trust (NYSE: CPT)Q3 2022 Earnings CallOct 28, 2022, 11:00 a.m. ET
Kim Callahan
Source Fool.com
Why Shares of Vertex Pharmaceuticals Jumped 9.03% on Friday
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX), a biopharmaceutical stock that specializes in cystic fibrosis (CF) and gene-editing therapies, saw its shares jump 9.03% on Friday. The stock closed
Why Medpace Holdings Jumped 41.5% This Week
Shares of Medpace Holdings (NASDAQ: MEDP), a clinical contract research organization (CRO) that supplies clinical development services to the biotechnology, pharmaceutical, and medical device
Why MSCI Stock Soared 18.3% This Week
MSCI (NYSE: MSCI) saw its stock price climb 18.3% higher this week from last Friday's close through the closing bell today, according to S&P Global Market Intelligence. The stock is down about 22%
Here's Why Apple Stock Soared Today
Shares of Apple (NASDAQ: AAPL) jumped 7.6% on Friday after the technology titan's sales and profits exceeded investors' expectations.
Apple's revenue rose 8% year over year to $90 billion in its
Why TAL Education Group Stock Popped Today
Shares of TAL Education Group (NYSE: TAL) jumped today after the Chinese education stock posted better-than-expected results in its second-quarter earnings report.
The stock finished the day up
Why Bed Bath & Beyond Stock Fell Today
Bed Bath & Beyond (NASDAQ: BBBY) was spiraling downward again today after two separate news items sparked concerns about the struggling home goods retailer.
The stock closed down 7.8%.
First, the
These 2 Stock Winners Topped Apple's Big Gains Friday
The stock market soared on Friday, ignoring one high-profile earnings miss among the largest companies in the market and instead focusing on the relatively solid performance from Apple (NASDAQ:
Is Texas Instruments Stock a Buy Now?
Texas Instruments (NASDAQ: TXN) posted its third-quarter earnings report on Oct. 25. The chipmaker's revenue rose 13% year over year to $5.24 billion, which beat analysts' estimates by $100 million
Crypto News: Why Bitcoin, Twitter, and Aptos Are Driving the Market Today
The crypto market has had a wild week from the "risk-on" trade early in the week to a steady climb and positive news late in the week. In the video below, Motley Fool contributor Travis Hoium covers
Veeva Systems Stock Hasn't Been This Cheap in Years -- Is It Time to Buy the Dip?
Stocks from all sectors have been pummeled in 2022. Those operating in the tech space have seen even more pain, given the fact that many are emerging players in their respective industries, posing


